Vol. 31 (2) 2024
Plasma metadherin mRNA expression in bladder cancer The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 28 – 43. www.Ejimmunology.org https://doi.org/10.55133/eji.310204 Zeinab A. Abd Elhameed1, Lubna M. Tag El Din1, Tahra Sherif1, Amal M. Abdel Aal1,...
Vol. 31 (2) 2024
Assessment of Stx-1A gene polymorphism (rs1569061) in relation to the development of multiple sclerosis in Egyptian patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 18 – 27. www.Ejimmunology.org https://doi.org/10.55133/eji.310203...
Vol. 31 (2) 2024
Identification of some variable parameters in serum of COVID-19 patients in comparison with control group The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 10 – 17. www.Ejimmunology.org https://doi.org/10.55133/eji.310202 Ebtihal C. Abbas1, Mais M....
Vol. 31 (2) 2024
Exploring the Correlation between Interleukin-17A Promoter Polymorphism at its -197 G/A and Rheumatoid Arthritis: Impact on Disease Severity and Activity The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 01 – 09. www.Ejimmunology.org...
Vol. 31 (1) 2024
Anti-inflammatory effect of high flux dialyzer surface area 2.6m2 in high flux hemodialysis and hemodiafiltration The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 184 – 192. www.Ejimmunology.org https://doi.org/10.55133/eji.310119 Hesham ElSayed,...
Vol. 31 (1) 2024
Evaluation of Interleukin-17 A Levels in Patients with Breast Carcinoma The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 174 – 183. www.Ejimmunology.org https://doi.org/10.55133/eji.310118 Heba M. El-Batal1, Mahmoud M. Kamel2,3, Inas Moaz4, and...
